β-Amyloid aggregation and heterogeneous nucleation.

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Beta-amyloid (β-amyloid) aggregation is central to amyloid diseases.
• Heterogeneous nucleation is a critical pathway in protein aggregation.
• Amyloid polymorphism is a defining characteristic, often arising during nucleation.

Purpose of the Study:

• To investigate the role of heterogeneous nucleation in β-amyloid aggregation.
• To identify key heterogeneous nucleators for β-amyloid.
• To understand the mechanisms by which nucleators influence aggregation.

Main Methods:

• Literature review and analysis of known β-amyloid nucleators.
• Focus on lipid surfaces (gangliosides, cholesterol) and divalent metal ions.
• Examination of peptide amphiphilicity in relation to nucleation.

Main Results:

• Heterogeneous nucleation is more prevalent and occurs at lower supersaturation than homogeneous nucleation.
• Lipid surfaces and divalent metal ions are significant heterogeneous nucleators for β-amyloid.
• The amphiphilic nature of β-amyloid peptides facilitates interaction with these nucleators.
• Cooperative interactions between different nucleator classes can enhance aggregation.

Conclusions:

• Heterogeneous nucleation is a primary driver of β-amyloid aggregation and polymorphism.
• Lipid surfaces and metal ions play crucial roles in initiating and modulating β-amyloid assembly.
• Understanding these nucleation pathways is vital for therapeutic strategies targeting amyloid diseases.